NCT01532167CompletedNot Applicable
Impact and Utility of Positron Emission Tomography (PET) for the Assessment of Inflammatory Activity Arteritis Versus Clinical Score and Laboratory Values in Takayasu Arteritis: a Cohort Study
Instituto Nacional de Cardiologia Ignacio Chavez1 site in 1 country26 target enrollmentStarted: February 2010Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 26
- Locations
- 1
Study Overview
Brief Summary
The purpose of this study is to demonstrate that [18F]FDG PET is a a better method than clinical and laboratory values for the identification and assessment of inflammatory activity in patients with Takayasu Arteritis (TA), allowing long-term follow-up with a precise evaluation of response to therapy.
Detailed Description
Inflammatory activity and fibrosis are the main causes of morbidity and mortality in patients with Takayasu arteritis. The investigators objective is to determine the utility of using 18F-FDG PET in the basal evaluation and follow-up of patients and compare the results with Dabague's clinical score.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •TA was diagnosed if the patient met 3 or more ACR criteria.
Exclusion Criteria
- Not provided
Investigators
Jose Telich
Investigator
Instituto Nacional de Cardiologia Ignacio Chavez
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Adaptive Pet StudyHead and Neck CancersLung and Esophagus CancersAnal, Cervix, Vulvar, Vaginal, and Endometrium CancersNCT01908504Duke University271
Completed
Not Applicable
Differential Diagnosis of Cognitive Disorders of Psychiatric or Neurodegenerative OriginNeurocognitive DisordersNCT06463093Central Hospital, Nancy, France20
Completed
Not Applicable
Positron Emission Tomography in Determining Stage of Esophageal CancerEsophageal CancerNCT00004867Alliance for Clinical Trials in Oncology235
Completed
Not Applicable
Fluorine F 18 EF5 Positron Emission Tomography in Assessing Hypoxia in Patients With Newly Diagnosed Stage I, Stage II, Stage III, or Stage IV Head or Neck Squamous Cell Cancer of the Oral Cavity, Oropharynx, and LarynxSquamous Cell CarcinomaNCT01020097Abramson Cancer Center at Penn Medicine5
Completed
Not Applicable
Role of18F-FDG PET-CT for Assessing and Predicting Response to Daratumumab and for Prognosis With Multiple MyelomaMultiple MyelomaNCT06170151IRCCS San Raffaele10